Prospective clinical trials. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Cell Line, Tumor

Diseases30

Breast Neoplasms Postoperative Complications Recurrence Lung Neoplasms Disease Progression Neoplasm Recurrence, Local Neoplasms Stroke HIV Infections Acute Disease Pain Chronic Disease Drug-Related Side Effects and Adverse Reactions Cardiovascular Diseases Myocardial Infarction Prostatic Neoplasms Diabetes Mellitus, Type 2 Neoplasm Metastasis Disease Models, Animal Colorectal Neoplasms Melanoma Heart Failure Nausea Weight Loss Arthritis, Rheumatoid Carcinoma, Non-Small-Cell Lung Fatigue Hemorrhage Brain Neoplasms Hypertension

Chemicals and Drugs42

Antineoplastic Agents Tumor Markers, Biological Immunosuppressive Agents Biological Markers Placebos Drugs, Investigational Drug Combinations Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Cancer Vaccines Anti-HIV Agents Anti-Bacterial Agents Paclitaxel Fluorouracil Antihypertensive Agents Anticoagulants Cardiovascular Agents Cyclophosphamide Hydroxymethylglutaryl-CoA Reductase Inhibitors Angiogenesis Inhibitors Cisplatin Platelet Aggregation Inhibitors Doxorubicin Anti-Inflammatory Agents Hypoglycemic Agents Methotrexate Deoxycytidine Immunologic Factors Anti-Infective Agents, Local Recombinant Proteins Fibrinolytic Agents Pyrroles Protein Kinase Inhibitors Antidepressive Agents Aspirin Piperazines Quinolines Antiviral Agents Sirolimus Plant Extracts Vitamins Pyrimidines

Analytical, Diagnostic and Therapeutic Techniques and Equipment106

Clinical Trials as Topic Prospective Studies Treatment Outcome Clinical Trials, Phase II as Topic Prognosis Follow-Up Studies Randomized Controlled Trials as Topic Antineoplastic Combined Chemotherapy Protocols Double-Blind Method Disease-Free Survival Retrospective Studies Combined Modality Therapy Predictive Value of Tests Drug Administration Schedule Clinical Trials, Phase III as Topic Survival Analysis Risk Factors Drug Therapy, Combination Neoplasm Staging Survival Rate Pilot Projects Kaplan-Meier Estimate Clinical Trials, Phase I as Topic Sensitivity and Specificity Chemotherapy, Adjuvant Research Design Controlled Clinical Trials as Topic Multivariate Analysis Reproducibility of Results Risk Assessment Tomography, X-Ray Computed Transplantation, Homologous Cohort Studies Patient Selection Multicenter Studies as Topic Placebos Clinical Trials, Phase IV as Topic Clinical Protocols Single-Blind Method Early Termination of Clinical Trials Sample Size Severity of Illness Index Endpoint Determination Administration, Oral Questionnaires Data Interpretation, Statistical Pain Measurement Drug Evaluation Feasibility Studies Cross-Over Studies Exercise Therapy Therapeutic Human Experimentation Drug Approval Random Allocation Meta-Analysis as Topic Infusions, Intravenous Phytotherapy Analysis of Variance Treatment Failure Drug Evaluation, Preclinical Immunotherapy Molecular Targeted Therapy Statistics, Nonparametric Genetic Therapy Proportional Hazards Models Incidence Control Groups Human Experimentation Models, Statistical Chi-Square Distribution Administration, Topical Regression Analysis Remission Induction Statistics as Topic Quality-Adjusted Life Years Disease Models, Animal Drug Delivery Systems Pain Management Disability Evaluation Physical Therapy Modalities Therapies, Investigational Magnetic Resonance Imaging Injections, Intramuscular Chemoprevention Data Collection Pragmatic Clinical Trials as Topic Drug Discovery Individualized Medicine Risk Drug Design Drug Therapy Probability Program Evaluation Injections, Intravenous Therapy, Computer-Assisted Odds Ratio Longitudinal Studies Logistic Models Linear Models Drug Monitoring Medicine, Chinese Traditional Self Care Musculoskeletal Manipulations Cluster Analysis Confidence Intervals Maximum Tolerated Dose

Psychiatry and Psychology11

Patient Compliance Cognitive Therapy Pain Counseling Behavior Therapy Motivation Smoking Cessation Decision Making Risk Reduction Behavior Psychiatric Status Rating Scales Health Knowledge, Attitudes, Practice

Phenomena and Processes16

Time Factors Sensitivity and Specificity Dose-Response Relationship, Drug Pain Pregnancy Recovery of Function Chi-Square Distribution Exercise Risk Weight Loss Probability Algorithms Odds Ratio Drug Resistance, Neoplasm Trial of Labor Maximum Tolerated Dose

Disciplines and Occupations14

Research Design Outcome Assessment (Health Care)Evidence-Based Medicine Biomedical Research Medical Oncology Therapeutic Human Experimentation Translational Medical Research Human Experimentation Statistics as Topic Comparative Effectiveness Research Drug Discovery Individualized Medicine Drug Design Research Report

Anthropology, Education, Sociology and Social Phenomena11

Quality of Life Informed Consent Drug Approval United States Food and Drug Administration Patient Education as Topic National Cancer Institute (U.S.)National Institutes of Health (U.S.)National Institute on Drug Abuse (U.S.)Exercise International Cooperation Medicine, Chinese Traditional

Technology, Industry, Agriculture4

Dietary Supplements Drug Industry Quality Control Vitamins

Humanities7

Quality of Life Ethics Committees, Research Therapeutic Equipoise Conflict of Interest Ethics, Research Ethical Review Ethics, Medical

Information Science15

Survival Rate Questionnaires Data Interpretation, Statistical Publishing Publication Bias Incidence Internet Quality-Adjusted Life Years Periodicals as Topic Data Collection Therapy, Computer-Assisted Algorithms Research Report Review Literature as Topic Databases, Factual

Named Groups4

Research Subjects Patient Dropouts Research Personnel Infant, Newborn

Health Care93

Clinical Trials as Topic Prospective Studies Treatment Outcome Clinical Trials, Phase II as Topic Follow-Up Studies Randomized Controlled Trials as Topic Double-Blind Method Disease-Free Survival Retrospective Studies Predictive Value of Tests Clinical Trials, Phase III as Topic Survival Analysis Risk Factors Survival Rate Pilot Projects Kaplan-Meier Estimate Clinical Trials, Phase I as Topic Sensitivity and Specificity Controlled Clinical Trials as Topic Multivariate Analysis Age Factors Reproducibility of Results Risk Assessment Cohort Studies Patient Selection Multicenter Studies as Topic Clinical Trials Data Monitoring Committees Clinical Trials, Phase IV as Topic Clinical Protocols Single-Blind Method Early Termination of Clinical Trials Sample Size Outcome Assessment (Health Care)Severity of Illness Index Cost-Benefit Analysis Patient Compliance Informed Consent Placebo Effect Questionnaires Data Interpretation, Statistical Patient Participation Feasibility Studies Cross-Over Studies Intention to Treat Analysis Random Allocation United States Food and Drug Administration Meta-Analysis as Topic Patient Education as Topic Patient Satisfaction Research Support as Topic Bias (Epidemiology)Analysis of Variance National Cancer Institute (U.S.)Guidelines as Topic Treatment Failure Practice Guidelines as Topic National Institutes of Health (U.S.)Ethics Committees, Research Statistics, Nonparametric Safety National Institute on Drug Abuse (U.S.)Proportional Hazards Models Incidence Counseling Models, Statistical Chi-Square Distribution Regression Analysis Statistics as Topic Quality-Adjusted Life Years Health Care Costs Cancer Care Facilities Comparative Effectiveness Research Selection Bias Pain Management Conflict of Interest Data Collection Pragmatic Clinical Trials as Topic Risk Ethics, Research Ethical Review Societies, Medical Probability Program Evaluation Health Knowledge, Attitudes, Practice Odds Ratio Longitudinal Studies Logistic Models Linear Models Ethics, Medical Eligibility Determination Self Care Cluster Analysis Confidence Intervals

Geographicals5

United States Great Britain Europe Canada Australia

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Prospective Studies Treatment Outcome Clinical Trials, Phase II as Topic Prognosis Follow-Up Studies Randomized Controlled Trials as Topic Time Factors Antineoplastic Combined Chemotherapy Protocols Double-Blind Method Antineoplastic Agents Disease-Free Survival Retrospective Studies Combined Modality Therapy Breast Neoplasms Predictive Value of Tests Drug Administration Schedule Clinical Trials, Phase III as Topic Survival Analysis Risk Factors Drug Therapy, Combination Neoplasm Staging Survival Rate Postoperative Complications Pilot Projects Kaplan-Meier Estimate Recurrence Tumor Markers, Biological Lung Neoplasms Clinical Trials, Phase I as Topic Sensitivity and Specificity Chemotherapy, Adjuvant Research Design Immunosuppressive Agents Disease Progression Neoplasm Recurrence, Local Controlled Clinical Trials as Topic Multivariate Analysis Age Factors Reproducibility of Results Risk Assessment Tomography, X-Ray Computed Biological Markers Transplantation, Homologous Cohort Studies Patient Selection Multicenter Studies as Topic Placebos Clinical Trials Data Monitoring Committees Clinical Trials, Phase IV as Topic Clinical Protocols Neoplasms Single-Blind Method Early Termination of Clinical Trials Sample Size Quality of Life Research Subjects United States Outcome Assessment (Health Care)Severity of Illness Index Endpoint Determination Cost-Benefit Analysis Evidence-Based Medicine Dose-Response Relationship, Drug Administration, Oral Patient Compliance Drugs, Investigational Informed Consent Placebo Effect Questionnaires Biomedical Research Medical Oncology Data Interpretation, Statistical Dietary Supplements Patient Participation Pain Measurement Drug Evaluation Feasibility Studies Cross-Over Studies Exercise Therapy Stroke Therapeutic Human Experimentation Drug Approval Intention to Treat Analysis Random Allocation United States Food and Drug Administration Meta-Analysis as Topic HIV Infections Drug Industry Drug Combinations Cognitive Therapy Antibodies, Monoclonal Infusions, Intravenous Patient Education as Topic Patient Dropouts Antibodies, Monoclonal, Humanized Phytotherapy Patient Satisfaction Research Support as Topic Bias (Epidemiology)

No FAQ available that match "prospective clinical trials"